Here are five takeaways:
1. The company raised $4 million.
2. This funds will be used to strengthen Ortho Kinematics cash position, as well as expand commercialization of the Vertebral Motion Analysis technology and the launch of several new product features.
3. The technology is intended for the radiographic assessment of spinal motion and instability.
4. The company has commercially tested its VMA technology with more than 4,000 patients.
5. The debt financing was largely led by TEXO Venture.
More articles on devices:
5 key trends in the global orthopedic biomaterials market
Bioventus expands team in Taiwan — 5 highlights
Zacks bumps RTI Surgical down to “sell” rating: 4 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.